Pediatrix (MD) Director Sylvia Young Receives 472-Share Award

What Happened

• Director Sylvia Jean Young was granted 472 restricted shares of Pediatrix Medical Group (MD) on 2026-08-12. The award is reported at a grant price of $26.50 per share, for a total reported value of $12,508. This transaction is an equity award (code A), not an open-market purchase or sale.

Key Details

• Transaction date and price: 2026-08-12 — 472 shares @ $26.50 (total $12,508).
• Filing: Form 4 filed 2026-08-14 (appears timely; Form 4s are generally due within two business days).
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: Granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan reflecting an increase to the annual equity award; shares vest on May 7, 2027.
• Transaction code meaning: A = award/grant.

Context

• Restricted stock grants are a common form of executive/director compensation and are subject to vesting (here, May 7, 2027), meaning they can be forfeited before vesting and are not immediate open-market investments. Such awards reflect compensation decisions rather than direct market buying or selling by the insider.